Početna stranicaFMS • NYSE
add
Fresenius Medical Care
23,17 $
Poslije radnog vremena:(0,00 %)0,00
23,17 $
Zatvoreno: 13. ožu, 16:00:24 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
24,19 $
Dnevni raspon
22,98 $ - 23,38 $
Godišnji raspon
17,93 $ - 25,25 $
Tržišna kapitalizacija
13,62 mlr. USD
Prosječna količina
295,43 tis.
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (EUR) | pro 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 5,08 mlr. | 1,94 % |
Operativni troškovi | 861,87 mil. | 0,88 % |
Neto dohodak | 66,90 mil. | −64,40 % |
Neto profitabilnost | 1,32 | −64,99 % |
Zarada po dionici | 0,91 | 3,41 % |
EBITDA | 610,39 mil. | −13,94 % |
Efektivna porezna stopa | 34,05 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (EUR) | pro 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 1,34 mlr. | −13,77 % |
Ukupna imovina | 33,57 mlr. | −1,07 % |
Ukupne obveze | 17,80 mlr. | −6,83 % |
Ukupni kapital | 15,77 mlr. | — |
Dionice u optjecaju | 293,41 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,49 | — |
Povrat imovine | 3,09 % | — |
Povrat kapitala | 3,87 % | — |
Tok novca
Neto promjena novca
| (EUR) | pro 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 66,90 mil. | −64,40 % |
Gotovina od poslovanja | 831,70 mil. | 15,66 % |
Gotovina iz ulaganja | −119,19 mil. | −23,52 % |
Gotovina iz financiranja | −965,18 mil. | −29,44 % |
Neto promjena novca | −201,88 mil. | −37,21 % |
Slobodan tok novca | 710,04 mil. | 25,26 % |
Više
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives.
With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan.
The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue.
The company is on the Best Employers List published by Forbes. Wikipedia
Glavni izvršni direktor
Osnovano
1996
Web-lokacija
Zaposlenici
111.513
